Modeling long-term persistence after 8 years of hepatitis B booster vaccination in 5- to 15-year-old children

References

• WHO. Hepatitis B. 2021 Jul 27 [accessed 2021 Dec 12]. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b
   Google Scholar
• Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012;30:2212–6. doi:10.1016/j.vaccine.2011.12.116.
   PubMed Web of Science ®Google Scholar
• Polaris Observatory Collaborators. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterol Hepatol. 2018;3:383–403. doi:10.1016/S2468-1253(18)30056-6.
   PubMed Web of Science ®Google Scholar
• Jing W, Liu J, Liu M. Eliminating mother-to-child transmission of HBV: progress and challenges in China. Front Med. 2020;14:21–29. doi:10.1007/s11684-020-0744-2.
   PubMed Web of Science ®Google Scholar
• Wang FS, Fan JG, Zhang Z, Gao B, Wang HY. The global burden of liver disease: the major impact of China. Hepatology. 2014;60:2099–108. doi:10.1002/hep.27406.
   PubMed Web of Science ®Google Scholar
• Kim YJ, Li P, Hong JM, Ryu KH, Nam E, Chang MS. A single center analysis of the positivity of hepatitis B antibody after neonatal vaccination program in Korea. J Korean Med Sci. 2017;32:810–16. doi:10.3346/jkms.2017.32.5.810.
   PubMed Web of Science ®Google Scholar
• Alssamei FAA, Al-Sonboli NA, Alkumaim FA, Alsayaad NS, Al-Ahdal MS, Higazi TB, Elagib AA. Assessment of immunization to hepatitis B vaccine among children under five years in rural areas of Taiz, Yemen. Hepat Res Treat. 2017;2017:1–6. doi:10.1155/2017/2131627.
   Google Scholar
• Qiu Y, Ren JJ, Wu ZK, Shen LZ, Shan H, Dai XW, Li J, Liu Y, Ren W, Yao J, et al. Strategies for hepatitis B booster vaccination among children: an 8-year prospective cohort study. Hum Vaccines Immunother. 2020;16:2822–30. doi:10.1080/21645515.2020.1738169.
   PubMed Web of Science ®Google Scholar
• Verbeke G, Molenberghs G. [Lecture notes in statistics] Linear mixed models in practice volume 126. New York: Springer-Verlag; 1997.
   Google Scholar
• Hens N, Habteab Ghebretinsae A, Hardt K, Van Damme P, Van Herck K. Model based estimates of long-term persistence of inactivated hepatitis a vaccine-induced antibodies in adults. Vaccine. 2014;32:1507–13. doi:10.1016/j.vaccine.2013.10.088.
   PubMed Web of Science ®Google Scholar
• Schwarz G. Estimating the dimension of a model. Ann Stat. 1978;6:461–64. doi:10.1214/aos/1176344136.
   Web of Science ®Google Scholar
• Wang ZZ, Gao YH, Wei L, Jin CD, Zeng Y, Yan L, Ding F, Li T, Liu X-E, Zhuang H, et al. Long-Term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China. Hum Vaccines Immunother. 2017;13:909–15. doi:10.1080/21645515.2016.1250990.
   PubMed Web of Science ®Google Scholar
• Zanetti A, Desole MG, Romanò L, D’-Alessandro A, Conversano M, Ferrera G, Panico MG, Tomasi A, Zoppi G, Zuliani M, et al. Safety and immune response to a challenge dose of hepatitis B vaccine in healthy children primed 10 years earlier with hexavalent vaccines in a 3, 5, 11-month schedule: an open-label, controlled, multicentre trial in Italy. Vaccine. 2017;35:4034–40. doi:10.1016/j.vaccine.2017.05.047.
   PubMed Web of Science ®Google Scholar
• Avdicova M, Crasta PD, Hardt K, Kovac M. Lasting immune memory against hepatitis B following challenge 10-11 years after primary vaccination with either three doses of hexavalent DTPa HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 a 11-12 months of age. Vaccine. 2015;33:2727–33. doi:10.1016/j.vaccine.2014.06.070.
   PubMed Web of Science ®Google Scholar
• Van Der Meeren O, Behre U, Crasta P. Immunity to hepatitis B persists in adolescents 15-16 years of age vaccinated in infancy with three doses of hepatitis B vaccine. Vaccine. 2016;34:2745–49. doi:10.1016/j.vaccine.2016.04.013.
   PubMed Web of Science ®Google Scholar
• Norrozi M, Azami A, Sarraf-Neduad A, Chitsaz H, Rahmati N. Persistence of anti-HBs antibody and immune memory to hepatitis B vaccine, 18 years after infantile vaccination in students of Tehran University. Res Med. 2016;40:36–41.
   Google Scholar
• Gottlieb S, Martin M, McLaughlin FX, Panaro RJ, Levine L, Edsall G. Long-Term immunity to diphtheria and tetanus: a mathematical model. Am J Epidemiol. 1967;85:207–19. doi:10.1093/oxfordjournals.aje.a120684.
   PubMed Web of Science ®Google Scholar
• Honorati MC, Palareti A, Dolzani P, Busachi CA, Rizzoli R, Facchini A. A mathematical model predicting anti-hepatitis B virus surface antigen (HBs) decay after vaccination against hepatitis B. Clin Exp Immunol. 1999;116:121–26. doi:10.1046/j.1365-2249.1999.00866.x.
   PubMed Web of Science ®Google Scholar
• Vellinga A, Van Damme P, Bruckers L, Weyler JJ, Molenberghs G, Meheus A. Modelling long-term persistence of hepatitis B antibodies after vaccination. J Med Virol. 1999;57:100–03. doi:10.1002/(SICI)1096-9071(199902)57:2<100:AID-JMV2>3.0.CO;2-M.
   PubMed Web of Science ®Google Scholar
• Coursaget P, Yvonnet B, Gilks WR, Wang CC, Day NE, Chiron JP, et al. Scheduling of revaccination against hepatitis B virus. Lancet. 1991;337:1180–83.
   PubMed Web of Science ®Google Scholar
• Gesemann M, Scheiermann N. Quantification of hepatitis B vaccine-induced antibodies as a predictor of anti-HBs persistence. Vaccine. 1995;13:443–47. doi:10.1016/0264-410X(94)00010-K.
   PubMed Web of Science ®Google Scholar
• Luo FJ, Dong CM, Shen YG, Huang CJ. Application of exponent curve model to study the hepatitis B DNA recombinant yeast derived vaccine antibody levels [abstract in English]. Chin J Epidemiol. 2004;25:805–07.
   Google Scholar
• Van Damme P, Leroux-Roels G, Suryakiran P, Folschweiller N, Van Der Meeren O. Persistence of antibodies 20 y after vaccination with a combined hepatitis a and B vaccine. Hum Vaccines Immunother. 2017;13:972–80. doi:10.1080/21645515.2016.1274473.
   PubMed Web of Science ®Google Scholar
• National Bureau of Statistics. The seventh national census bulletin (No. 8). 2021 May 11[accessed 2021 Dec 12]. http://www.stats.gov.cn/ztjc/zdtjgz/zgrkpc/dqcrkpc/ggl/202105/t20210519_1817701.html
   Google Scholar
• Qiu Y, Ren JJ, Yao J. Healthy adult vaccination: an urgent need to prevent hepatitis B in China. Hum Vaccines Immunother. 2016;12:773–78. doi:10.1080/21645515.2015.1086519.
   PubMed Web of Science ®Google Scholar